Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-003498

Co-Chief Executive Officer gave up 2,057 shares (to pay taxes)

  • Co-Chief Executive Officer acquired 4,687 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MOHANTY ADITYA P. Co-Chief Executive Officer 2018-01-10 Option exercise +4,687 97,309 D: show line 1 in the form
MOHANTY ADITYA P. Co-Chief Executive Officer 2018-01-10 Shares withheld for taxes −2,057 $2.68 $5,513 95,252 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
MOHANTY ADITYA P. Co-Chief Executive Officer 2018-01-10 Option exercise · Restricted Stock Units −4,687 42,188 D: show line 3 in the form
Loading xslF345X03/doc4.xml…